<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">These findings are relevant to SARS-CoV-2 because the spike proteins of the SARS-CoV and SARS-CoV-2 are related (73%), and they share binding specificity to the human receptor, ACE2 (
 <xref rid="bib15" ref-type="bibr">Zhou et al., 2020</xref>). Patients who have recovered from SARS-CoV-2 infection develop neutralizing antibodies (
 <xref rid="bib13" ref-type="bibr">Wölfel et al., 2020</xref>). Golden Syrian hamsters that were experimentally infected with SARS-CoV-2 developed neutralizing antibodies and were protected from reinfection. Furthermore, as was the case with SARS-CoV, passive transfer of serum from previously infected hamsters to naive hamsters conferred protection from subsequent challenge (
 <xref rid="bib2" ref-type="bibr">Chan et al., 2020</xref>).
</p>
